Secretory factors from human adipose tissue and their functional role

被引:311
作者
Hauner, H [1 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Else Kroner Fresenius Ctr Nutr Med, D-81675 Munich, Germany
关键词
D O I
10.1079/PNS2005428
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Obesity is characterized by an expanded adipose tissue mass. Recent data suggest that adipose tissue is a multi-functional organ rather than simply a passive storage site for excess energy. It has been clearly demonstrated that human adipose tissue produces a variety of secretory factors that exert multiple effects at both the local and the systemic level. To date, > 100 products, covering a broad range of protein families as well as many fatty acids and prostaglandins, have been reported to be secreted by adipose tissue. The source of these secreted factors is not only mature fat cells but also poorly-identified cells present in the stromal-vascular fraction including macrophages. Secreted factors of particular interest include many cytokines or chemokines, such as TNF-alpha, IL-6, IL-8, as well as plasminogen activator inhibitor-1, angiotensin-II, leptin, and adiponectin. In the obese state the expression and secretion of these factors is disturbed. With the exception of adiponectin, most circulating factors are elevated. From this perspective, obesity can be described as a pro-inflammatory condition. In addition, regional differences in adipose expression of many of these factors have been found. There is now growing evidence that many secretory factors play an important role in the pathophysiology of the metabolic and cardiovascular complications of obesity. The question arising from these observations is how the secretory pattern of adipose tissue can be modified by dietary and pharmacological measures to reduce the health risks of obesity.
引用
收藏
页码:163 / 169
页数:7
相关论文
共 50 条
  • [1] Ailhaud G, 2004, HDB OBESITY ETIOLOGY, P481
  • [2] Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease
    Alessi, MC
    Peiretti, F
    Morange, P
    Henry, M
    Nalbone, G
    JuhanVague, I
    [J]. DIABETES, 1997, 46 (05) : 860 - 867
  • [3] ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism
    Berg, AH
    Combs, TP
    Scherer, PE
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (02) : 84 - 89
  • [4] The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
    Berg, AH
    Combs, TP
    Du, XL
    Brownlee, M
    Scherer, PE
    [J]. NATURE MEDICINE, 2001, 7 (08) : 947 - 953
  • [5] Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes
    Birgel, M
    Gottschling-Zeller, H
    Röhrig, K
    Hauner, H
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) : 1682 - 1687
  • [6] Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
    Boden, G
    [J]. DIABETES, 1997, 46 (01) : 3 - 10
  • [7] Immnohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture
    Bornstein, SR
    Abu-Asab, M
    Glasow, A
    Päth, G
    Hauner, H
    Tsokos, M
    Chrousos, GP
    Scherbaum, WA
    [J]. DIABETES, 2000, 49 (04) : 532 - 538
  • [8] A role for preadipocytes as macrophage-like cells
    Cousin, B
    Munoz, O
    Andre, M
    Fontanilles, AM
    Dani, C
    Cousin, JL
    Laharrague, P
    Casteilla, L
    Pénicaud, L
    [J]. FASEB JOURNAL, 1999, 13 (02) : 305 - 312
  • [9] DIFFERENTIATION OF PREADIPOSE CELLS - PARACRINE ROLE OF PROSTACYCLIN UPON STIMULATION OF ADIPOSE-CELLS BY ANGIOTENSIN-II
    DARIMONT, C
    VASSAUX, G
    AILHAUD, G
    NEGREL, R
    [J]. ENDOCRINOLOGY, 1994, 135 (05) : 2030 - 2036
  • [10] Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes
    Dietze, D
    Koenen, M
    Röhrig, K
    Horikoshi, H
    Hauner, H
    Eckel, J
    [J]. DIABETES, 2002, 51 (08) : 2369 - 2376